Allergy

Further, fewer than half of people who suffer from chronic nasal congestion seek help from a specialist to look deeper at the cause of their chronic problem.

Face mask usage may help, and pharmacists can provide other education and guidance about safe and proper use of nonprescription medications.

The FDA has expanded its approval of short ragweed pollen allergen extract (Ragwitek; ALK) to include treatment for children and adolescents, starting at age 5 years, with short ragweed pollen-induced allergic rhinitis.

With allergy season under way, pharmacists can help patients identify triggers and coach them on how to manage.

Second-generation antihistamines are safer and just as affordable and as effective as first-generation antihistamines, according to the study authors.

Research is the first to link chronic sinus inflammation with a neurobiological change.

Intranasal administration of virucidal and antiviral therapies may provide added clinical benefit by decreasing viral activity in the nasal pathway, preventing COVID-19 transmission and managing disease severity.

In a recent interview with Pharmacy Times, Jennifer Maloney, MD, of Regeneron, said an investigative new drug may help patients manage their cat allergies.

Study findings suggest that many individuals who report peanut allergies and experience potentially severe allergic reactions are not obtaining clinical diagnosis of their allergies.

Push continues for more access to EpiPens, but it is important to protect health care providers who administer the treatment.

Among a subset of participants in the COVID-19 vaccine clinical trials, 0.63% of individuals in the vaccinated group had hypersensitivity-related adverse events that may represent allergic reactions.

Although it is commonly known that children experience bullying over food allergies, new research suggests that parents and guardians do as well.

In the study, more patients with allergies had chronic obstructive pulmonary disease (COPD), which is a known risk factor for severe disease with COVID-19.

The patient was prescribed prednisone for the rash when he was seen by emergency department physicians, and a follow up telehealth visit with the hospital’s allergy clinic was done when the patient’s symptoms were not relieved.

The study used an animal model that was conducted according to the National Advisory Committee for Laboratory Animal Research (NACLAR) guidelines.

Peanut allergies affect approximately 1.2% of the entire US population and an estimated 2.5% of the childhood population.

Patients with allergic rhinitis who received allergen immunotherapy exhibited a clinical improvement in symptoms compared with those who received standard pharmacotherapy alone.

Researchers believe the progression of allergies begins with eczema in infancy before progressing to food allergies, asthma, and hay fever later in childhood.

Although some similarities exist, a few key differences can help differentiate the symptoms.

Study finds that few documented antibiotic allergies are correct, and family physicians and pharmacists do not have sufficient knowledge on the issue.

Palforzia is an oral immunotherapy agent for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.

This generic drug product was determined by the FDA to be therapeutically equivalent to Adrenalin.

Two retail pharmacy case studies are presented.

Pharmacists should understand their mechanisms to facilitate high-quality, collaborative management with physicians.

Rx products features in the April 2020 issue.

Over-the-counter products featured in the April 2020 issue of Pharmacy Times.

Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

The FDA has approved olopatadine hydrochloride ophthalmic 0.1% and 0.2% solution for sale as an OTC medication in the United States.